Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 4
2004 1
2005 1
2006 2
2008 2
2009 6
2010 14
2011 17
2012 13
2013 22
2014 18
2015 14
2016 16
2017 16
2018 11
2019 13
2020 9
2021 9
2022 8
2023 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

167 results

Results by year

Filters applied: . Clear all
Page 1
Two Phase 3 Trials of Gantenerumab in Early Alzheimer's Disease.
Bateman RJ, Smith J, Donohue MC, Delmar P, Abbas R, Salloway S, Wojtowicz J, Blennow K, Bittner T, Black SE, Klein G, Boada M, Grimmer T, Tamaoka A, Perry RJ, Turner RS, Watson D, Woodward M, Thanasopoulou A, Lane C, Baudler M, Fox NC, Cummings JL, Fontoura P, Doody RS; GRADUATE I and II Investigators and the Gantenerumab Study Group. Bateman RJ, et al. N Engl J Med. 2023 Nov 16;389(20):1862-1876. doi: 10.1056/NEJMoa2304430. N Engl J Med. 2023. PMID: 37966285 Clinical Trial.
A Multicentre, Randomised, Open-Label, Prospective Study to Estimate the Add-On Effects Of Memantine as Ebixa® Oral Pump (Solution) on Language in Patients with Moderate to Severe Alzheimer's Disease Already Receiving Donepezil (ROMEO-AD).
Kim HJ, Shim Y, Han HJ, Kim BC, Park KH, Moon SY, Choi SH, Yang DW, Yoon B, Kim EJ, Jeong JH, Han SH. Kim HJ, et al. Among authors: han sh. Neurol Ther. 2023 Aug;12(4):1221-1233. doi: 10.1007/s40120-023-00494-5. Epub 2023 May 28. Neurol Ther. 2023. PMID: 37245175 Free PMC article.
Corrigendum to "Glucose deprivation reversibly down-regulates tissue plasminogen activator via proteasomal degradation in rat primary astrocytes" [Life Sci. 92 (2013) 929-937].
Cho KS, Joo SH, Choi CS, Kim KC, Ko HM, Park JH, Kim P, Lee SH, Bahn GH, Ryu JH, Lee J, Han SH, Kwon KJ, Shin CY. Cho KS, et al. Among authors: han sh. Life Sci. 2022 Oct 1;306:120796. doi: 10.1016/j.lfs.2022.120796. Epub 2022 Jul 15. Life Sci. 2022. PMID: 35851480 No abstract available.
A Multinational, Multicenter, Randomized, Double-Blind, Active Comparator, Phase III Clinical Trial to Evaluate the Efficacy and Safety of Donepezil Transdermal Patch in Patients With Alzheimer's Disease.
Han HJ, Park MY, Park KW, Park KH, Choi SH, Kim HJ, Yang DW, Ebenezer EGAM, Yang YH, Kewalram GM, Han SH; on Behalf the IPI-301 Study. Han HJ, et al. Among authors: han sh. J Clin Neurol. 2022 Jul;18(4):428-436. doi: 10.3988/jcn.2022.18.4.428. J Clin Neurol. 2022. PMID: 35796268 Free PMC article.
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase IIb Clinical Study to Evaluate the Safety and Efficacy of DHP1401 in Patients with Mild to Moderate Alzheimer's Disease Treated with Donepezil: DHP1401 Randomized Trial in Mild to Moderate Alzheimer's Disease (DRAMA).
Shim Y, Han HJ, Park KW, Kim BC, Park KH, Park MY, Kim HJ, Moon SY, Choi SH, Park KW, Yang DW, Yoon SJ, Kim SY, Youn YC, Choi H, Yoon KE, Cho HJ, Han SH. Shim Y, et al. Among authors: han sh. J Alzheimers Dis. 2022;87(1):391-403. doi: 10.3233/JAD-215277. J Alzheimers Dis. 2022. PMID: 35275529 Clinical Trial.
167 results